2012
DOI: 10.4103/0971-6866.96680
|View full text |Cite
|
Sign up to set email alerts
|

Methylenetetrahydrofolate reductase mutations, a genetic cause for familial recurrent neural tube defects

Abstract: Methylenetetrahydrofolate reductase (MTHFR) gene mutations have been implicated as risk factors for neural tube defects (NTDs). The best-characterized MTHFR genetic mutation 677C→T is associated with a 2–4 fold increased risk of NTD if patient is homozygous for this mutation. This risk factor is modulated by folate levels in the body. A second mutation in the MTHFR gene is an A→C transition at position 1298. The 1298A→C mutation is also a risk factor for NTD, but with a smaller relative risk than 677C→T mutati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 5 publications
0
17
0
1
Order By: Relevance
“…MTHFR enzyme deficiency was calculated by adding up the total loss of enzymatic functions from both MTHFR C677T and A1298C polymorphisms, 35% for 677 CT and 70% for 677 TT polymorphisms, and 15% for 1298 AC and 30% for 1298 CC variants [ 20 , 21 , 58 ]. The total gene mutations from five genes were computed together, with possible ranges of 0–10, with scores of one for heterozygous and two for homozygous polymorphism mutations per each of the five genes included in this study.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…MTHFR enzyme deficiency was calculated by adding up the total loss of enzymatic functions from both MTHFR C677T and A1298C polymorphisms, 35% for 677 CT and 70% for 677 TT polymorphisms, and 15% for 1298 AC and 30% for 1298 CC variants [ 20 , 21 , 58 ]. The total gene mutations from five genes were computed together, with possible ranges of 0–10, with scores of one for heterozygous and two for homozygous polymorphism mutations per each of the five genes included in this study.…”
Section: Methodsmentioning
confidence: 99%
“…We examined two loci of MTHFR gene polymorphisms, C677T (rs1801133) and A1298C (rs1801131), both are associated with MTHFR enzymatic deficiency resulting in increased homocysteine concentrations [ 18 , 19 ]. The best-characterized MTHFR gene polymorphism is a common missense/loss of function mutation of 677C→T, resulting in a thermolabile enzyme variant that has a reduced catalytic activity of 35% for 677 CT and 70% for 677 TT variants, and of nucleotide 1298A→C, resulting in 15% decreased MTHFR activity for 1298 AC and 30% for 1298 CC variants [ 20 , 21 ]. We also investigated three additional genes in the folate-methylation pathways: dihydrofolate reductase ( DHFR ) 19 base pair ( 19bp ) (rs70991108) which converts folic acid into methylenetetrahydrofolate (MTHF) as usable folate form [ 22 , 23 ], methionine synthase ( MTR A2756G, rs1805087) in the methylation cycle, and methionine synthase reductase ( MTRR A66G, rs1801394) which converts/recycles homocysteine back to usable MTR for the methylation cycle [ 24 , 25 , 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, the identification of the rs1801133 genotype is necessary not only for the study of this SNP involving in human diseases but also for the prognosis of treatment with anti-cancer drugs as well as identification of molecular causes of some human diseases. Another application of rs1801133 genotyping is the prediction of the risk of neonatal illness [13]. In fact, there are many molecular protocols/commercial kits for genotyping rs1801133.…”
Section: Introduction Ethylenetetrahydrofolate Reductase (Mthfr)mentioning
confidence: 99%
“…Key methyl-donors related to these genes include folate (vitamin B9) and vitamin B12, that play an integral role in the phenotypic expression of MTHFR and related gene mutations in the OCM methylation pathways [ 33 , 34 , 35 , 36 ]. The methyl-donors could compensate for the deficient enzyme-metabolites in the methylation pathways resulted from the loss-of-function gene mutations in the OCM pathway.…”
Section: Introductionmentioning
confidence: 99%